Coeptis Therapeutics Holdings, Inc. financial data

Symbol
COEP, COEPW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
105 Bradford Road, Suite 420, Wexford, PA
State of incorporation
DE
Fiscal year end
December 31
Former names
Bull Horn Holdings Corp. (to 10/28/2022)
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 45.2 % -61.7%
Debt-to-equity 426 % +136%
Return On Equity -1.07K % -19.7%
Return On Assets -215 % +32.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 41.1M shares +20.6%
Common Stock, Shares, Outstanding 40M shares +21.2%
Entity Public Float 28.8M USD -42.4%
Common Stock, Value, Issued 4K USD +21.2%
Weighted Average Number of Shares Outstanding, Basic 39.8M shares +49.4%
Weighted Average Number of Shares Outstanding, Diluted 39.8M shares +49.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
Cost of Revenue 0 USD
Research and Development Expense 3M USD -46.9%
Selling and Marketing Expense 0 USD -100%
General and Administrative Expense 3.82M USD -36.4%
Operating Income (Loss) -11.3M USD +47%
Nonoperating Income (Expense) -363K USD -147%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -11.6M USD +43.2%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -11.6M USD +43.2%
Earnings Per Share, Basic -0.25 USD/shares +65.8%
Earnings Per Share, Diluted -0.25 USD/shares +65.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 13.8K USD -97.6%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Assets, Current 1.36M USD -15.8%
Property, Plant and Equipment, Net 10.7K USD -8.12%
Operating Lease, Right-of-Use Asset 69.6K USD +143%
Assets 8.96M USD +91.7%
Accounts Payable, Current 1.13M USD +135%
Accrued Liabilities, Current 742K USD +30.9%
Liabilities, Current 3.44M USD +53.9%
Operating Lease, Liability, Noncurrent 61.2K USD +316%
Liabilities 3.97M USD +43%
Retained Earnings (Accumulated Deficit) -95.2M USD -13.9%
Stockholders' Equity Attributable to Parent 4.82M USD +155%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 4.98M USD +163%
Liabilities and Equity 8.96M USD +91.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.9M USD -12.9%
Net Cash Provided by (Used in) Financing Activities 1.56M USD
Net Cash Provided by (Used in) Investing Activities -100K USD
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 40M shares +21.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.14M USD -19.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 23.1M USD +23.2%
Deferred Tax Assets, Gross 23.1M USD +23.2%
Operating Lease, Liability 71.1K USD +179%
Payments to Acquire Property, Plant, and Equipment 0 USD
Lessee, Operating Lease, Liability, to be Paid 76.8K USD +156%
Property, Plant and Equipment, Gross 25.2K USD 0%
Operating Lease, Liability, Current 9.89K USD -8.06%
Lessee, Operating Lease, Liability, to be Paid, Year Two 46K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 11.4K USD -39.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.69K USD +26%
Lessee, Operating Lease, Liability, to be Paid, Year Three 19.3K USD
Deferred Tax Assets, Operating Loss Carryforwards 22.5M USD +21.9%
Preferred Stock, Shares Issued 5.83K shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 102M USD +16.1%
Preferred Stock, Shares Outstanding 5.83K shares
Depreciation, Depletion and Amortization 250K USD -0.04%
Interest Expense 300K USD +73.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%